Apollo widens pricing, tightens covenants on LifePoint buyout debt

Apollo-sponsored RCCH Healthcare Partners made investor-friendly changes to the bonds and loans it sold this week to support its acquisition of LifePoint Health, widening the pricing as well as tightening the covenants in the debt package.

  • By David Bell
  • 13 Nov 2018

The $5bn of debt across a high yield bond and a first lien loan was priced on Wednesday, after leads shifted the structure, pricing and covenants in the deal.

Two buy-side sources said the deal had a tough ...

Please take a trial or subscribe to access this content.

Contact our subscriptions team to discuss your access: subs@globalcapital.com

Corporate access

To discuss GlobalCapital access for your entire department or company please contact our subscriptions sales team at: subs@globalcapital.com or find out more online here.

Bookrunners of European Leveraged Loans

Rank Lead Manager Amount $m No of issues Share %
  • Last updated
  • Today
1 Credit Agricole CIB 484.94 3 17.32%
1 BNP Paribas 484.94 3 17.32%
3 SG Corporate & Investment Banking 194.57 2 6.95%
3 HSBC 194.57 2 6.95%
5 Natixis 174.13 2 6.22%

Bookrunners of European HY Bonds

Rank Lead Manager Amount €m No of issues Share %
  • Last updated
  • Today
1 Citi 397.10 3 12.77%
2 JPMorgan 300.50 3 9.66%
3 Deutsche Bank 200.50 2 6.45%
4 Credit Agricole CIB 193.60 2 6.22%
5 UBS 187.50 2 6.03%

Bookrunners of Dollar Denominated HY Bonds

Rank Lead Manager Amount $m No of issues Share %
  • Last updated
  • Today
1 Citi 3,219.24 22 10.20%
2 JPMorgan 2,544.70 20 8.06%
3 Credit Suisse 2,364.95 15 7.49%
4 Goldman Sachs 2,331.78 17 7.39%
5 Barclays 2,307.33 19 7.31%